BGM

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.05
Percentage change 0.38	%

Peers: CAH MCK A TMO ILMN LH DGX CRL BIO CCEC

| Held by: ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.20	Insider Own	81.93%	Shs Outstand	183.96M	Perf Week	-2.81%
Market Cap	2.41B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	33.25M	Perf Month	6.23%
Enterprise Value	2.40B	PEG	-	EPS next Q	-	Inst Own	0.05%	Short Float	0.05%	Perf Quarter	28.12%
Income	-1.44M	P/S	96.16	EPS this Y	-	Inst Trans	-80.27%	Short Ratio	0.35	Perf Half Y	53.81%
Sales	25.10M	P/B	2.22	EPS next Y	-	ROA	-2.77%	Short Interest	0.02M	Perf YTD	55.27%
Book/sh	5.91	P/C	133.05	EPS next 5Y	-	ROE	-3.37%	52W High	17.17 -23.59%	Perf Year	264.24%
Cash/sh	0.10	P/FCF	-	EPS past 3/5Y	- -	ROIC	-3.38%	52W Low	2.80 368.57%	Perf 3Y	59.06%
Dividend Est.	-	EV/EBITDA	3577.27	Sales past 3/5Y	-23.97% -11.45%	Gross Margin	11.47%	Volatility	6.10% 9.95%	Perf 5Y	-
Dividend TTM	-	EV/Sales	95.49	EPS Y/Y TTM	81.70%	Oper. Margin	-2.25%	ATR (14)	1.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.73	Sales Y/Y TTM	-45.99%	Profit Margin	-5.75%	RSI (14)	49.67	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	3.39	EPS Q/Q	77.80%	SMA20	-4.24%	Beta	1.39	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-27.57%	SMA50	7.62%	Rel Volume	2.35	Prev Close	13.07
Employees	323	LT Debt/Eq	0.00	Earnings	-	SMA200	36.73%	Avg Volume	43.22K	Price	13.12
IPO	Jan 12, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	102,891	Change	0.38%

May-28-25 04:30PM	From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts (PR Newswire) -18.89% +20.35%
May-02-25 08:30AM	BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem (PR Newswire)
Apr-28-25 08:30AM	BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform (PR Newswire)
Apr-21-25 08:30AM	BGM Group Acquires Wonder Dragon to Accelerate 'Healthcare' Strategy (PR Newswire)
Mar-19-25 08:30AM	BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform (PR Newswire)
08:30AM	Loading…
Feb-28-25 08:30AM	BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution (PR Newswire)
Feb-19-25 07:30AM	BGM Group Establishes 'Duxiaobao Management Committee' to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry (PR Newswire)
Dec-27-24 09:30AM	BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth (PR Newswire)
09:05AM	In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI (PR Newswire)
09:00AM	AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare (GlobeNewswire)
Dec-19-24 08:30AM	BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development (PR Newswire)
Nov-29-24 10:58AM	BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech (PR Newswire) +22.50%
10:58AM	/C O R R E C T I O N -- BGM Group Ltd/ (PR Newswire)
10:11AM	AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead? (PR Newswire)
09:00AM	AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI (GlobeNewswire)
06:32AM	Loading…
Nov-28-24 06:32AM	Qilian International Announces Major Share Subscription Deal (TipRanks)
Nov-22-24 08:30AM	BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development (PR Newswire)
Oct-29-24 08:00AM	Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd. (PR Newswire)
Aug-13-24 08:00AM	Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" (PR Newswire)

BGM Group Ltd. is a pharmaceutical and chemical company. It focuses on the research, development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Licorice products include Gan Di Xin, Qilian Shan Licorice Extract, and Qilian Shan Licorice Liquid Extract. The Oxytetracycline products consists of Qilian Shan Oxytetracycline Tablets and Qilian Shan Oxytetracycline Active Pharmaceutical Ingredients (API). The TCMD product includes Ahan antibacterial paste, which is made from a mixture of traditional Chinese herbal ingredients. The heparin product includes Heparin Sodium Preparations. The Sausage Casings products include Zhu Xiaochang Sausage Casings, which are all-natural food products used for culinary purposes. The Fertilizer products is composed of Xiongguan Organic Fertilizer and Xiongguan Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BGM Group Ltd

Upgrade your FINVIZ experience